Clinical Trial Applications - Approved: Filter, Search, and view applications
| # | Protocol No | Study Title | Investigator(s) & Site(s) | Date Approved | |
|---|---|---|---|---|---|
41. |
ECCT/17/03/01 | The POWER cohort A cohort for evaluation of open-label PrEP delivery among Kenyan and South African women |
Principal Investigator(s) 1. Dr. Stella Njuguna Site(s) in Kenya 1. Jaramogi Oginga Odinga Teaching and Referral Hospital. (Kisumu county) |
04-05-2017 |
View |
42. |
ECCT/17/03/03 | FLACSAM First Line Antimicrobials in Children with Complicated Severe Acute Malnutrition |
Principal Investigator(s) 1. James Berkley Site(s) in Kenya 1. Kilifi County Hospital (Kilifi county) 2. Coast General Hospital (Mombasa county) 3. Mbagathi Hospital (Nairobi City county) |
21-06-2017 |
View |
43. |
ECCT/17/05/02 | The Anza Mapema Study Expanding test and treat for HIV prevention in MSM in Kisumu, Kenya: The Anza Mapema Study |
Principal Investigator(s) 1. Fredrick Odhiambo Otieno Site(s) in Kenya Anza Mapema Study Clinic |
01-09-2017 |
View |
44. |
ECCT/17/07/01 | ABCD Antibiotics for Children with Severe Diarrhea Trial |
Principal Investigator(s) 1. Judd Walson Site(s) in Kenya 1. Rongo Sub-County Hospital (Migori county) 2. Ndhiwa Sub-County Hospital (Homa Bay county) 3. Rachuonyo Sub-County Hospital (Homa Bay county) 4. Isebania Sub-County Hospital (Migori county) 5. Awendo Sub-County Hospital (Migori county) 6. Mbita Sub-County Hospital (Homa Bay county) |
01-12-2017 |
View |
45. |
ECCT/17/08/01 | A trial to compare the safety and immune response of the normal full and reduced doses of yellow fever vaccines in Kenyan adults A Phase IV randomized, double blinded non-inferiority trial on the immunogenicity and safety of fractional doses of yellow fever vaccines. |
Principal Investigator(s) 1. Philip Bejon Site(s) in Kenya KEMRI Kilifi |
07-09-2017 |
View |
46. |
ECCT/17/08/04 | P1081 A PHASE IV RANDOMIZED TRIAL TO EVALUATE THE VIROLOGIC RESPONSE AND PHARMACOKINETICS OF TWO DIFFERENT POTENT REGIMENS IN HIV INFECTED WOMEN INITIATING TRIPLE ANTIRETROVIRAL REGIMENS BETWEEN 28 AND 36 WEEKS OF PREGNANCY FOR THE PREVENTION OF MOTHER-TO-CHILD TRANSMISSION: NICHD P1081 |
Principal Investigator(s) 1. FREDRICK KIPYEGON SAWE Site(s) in Kenya Kenya Medical Research Institute Walter Reed Project Clinical Research Centre. |
13-11-2017 |
View |
47. |
ECCT/17/08/06 | Enhancing Preventive Therapy of Malaria In children with Sickle cell anemia in East Africa (EPiTOMISE) Enhancing Preventive Therapy of Malaria In children with Sickle cell anemia in East Africa (EPiTOMISE) |
Principal Investigator(s) 1. Festus Muigai Njuguna Site(s) in Kenya Homa Bay County Hospital |
03-10-2017 |
View |
48. |
ECCT/18/03/01 | JiPime JiPrEP (HIVST Study) HIV self-testing to improve the efficiency of PrEP delivery. |
Principal Investigator(s) 1. Kenneth Kairu Ngure Site(s) in Kenya KEMRI-CCR PHRD (THIKA) |
16-05-2018 |
View |
49. |
ECCT/18/04/02 | Maternal Influenza Vaccine Study Impact of HIV Infection and Malaria Parasitemia on Immunogenicity of Inactivated Influenza Vaccine in Pregnant Women and on Mother-to-Child Vaccine-induced Antibody Transfer |
Principal Investigator(s) 1. Sandra S Chaves Site(s) in Kenya 1. Siaya County Referral Hospital (Siaya county) 2. Bondo Sub-County Hospital (Siaya county) |
04-06-2018 |
View |
50. |
ECCT/18/05/02 | KINGA Study Immunogenetic Modulators of Mucosal Protection from HIV-1: The Kinga Study |
Principal Investigator(s) 1. Nelly Rwamba Mugo Site(s) in Kenya KEMRI-CCR - Partners in Health Research & Development (PHRD) Thika Site. |
26-07-2018 |
View |